[1]
Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998; 129(5): 345-52.
[http://dx.doi.org/10.7326/0003-4819-129-5-199809010-00001] [PMID: 9735061]
[http://dx.doi.org/10.7326/0003-4819-129-5-199809010-00001] [PMID: 9735061]
[2]
Puechal X, Iudici M, Calich AL, et al. Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: a single-centre cohort study on 114 patients. Rheumatology (Oxford) 58(3): 401-9.
[3]
Roubaud-Baudron C, Pagnoux C, Méaux-Ruault N, et al. French Vasculitis Study Group. Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis. J Rheumatol 2012; 39(1): 125-30.
[http://dx.doi.org/10.3899/jrheum.110143] [PMID: 22089465]
[http://dx.doi.org/10.3899/jrheum.110143] [PMID: 22089465]
[4]
Christl SU, Borchard F, Keller R, Engemann R, Fischbach W. Pancreatic tail tumor as an unusual first manifestation of Wegener’s disease. Z Gastroenterol 2004; 42(6): 513-6.
[http://dx.doi.org/10.1055/s-2004-813113] [PMID: 15190447]
[http://dx.doi.org/10.1055/s-2004-813113] [PMID: 15190447]
[5]
Chawla S, Atten MJ, Attar BM. Acute pancreatitis as a rare initial manifestation of Wegener’s granulomatosis. A case based review of literature. JOP: J Pancreas 2011; 12(2): 167-9.
[6]
Valerieva Y, Golemanov B, Tzolova N, Mitova R. Pancreatic mass as an initial presentation of severe Wegener’s granulomatosis. Ann Gastroenterol 2013; 26(3): 267-9.
[PMID: 24714250]
[PMID: 24714250]
Article Metrics
30
